π©Ί Weight loss meds help breast cancer survivors?
A phase 2 trial suggested that adding a non-GLP-1 weight-loss drug could help some breast cancer survivors reach their target weight. This study was conducted by researchers at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore. The trial enrolled 55 women, and 42% of those who needed extra help successfully reached a 5% weight loss threshold by six months. This intervention was used for women who couldn't lose weight enough through lifestyle changes alone. Larger studies are needed to confirm this threshold-based approach for prescribing these medications. π©Ί